Product logins

Find logins to all Clarivate products below.


Dialysis Access Treatment Devices | Market Insights | Europe (Supplemental) | 2025

Rising uptake percutaneous AVF catheters for dialysis creation and DCBs for dialysis maintenance will support growth in the European dialysis access treatment device market. The rising ESRD population and the launch of novel and innovative premium-priced products will drive market expansion, whereas cost constraints will hinder it to some extent.

This Medtech 360 Report provides high-level market metrics for dialysis access treatment devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe from 2019 through 2033.

Related Medtech Insights Reports

Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Cardiac Rhythm Management Devices – Market Insights – Europe
The European CRM device market will continue to grow modestly over the forecast period because of rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and increased…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…